Published in BMC Nephrol on December 24, 2012
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20
Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc (1985) 7.02
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Blood pressure and end-stage renal disease in men. N Engl J Med (1996) 5.68
Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol (2004) 5.29
Chronic kidney disease: the global challenge. Lancet (2005) 5.16
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis (2006) 4.26
Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol (2010) 4.06
Proteinuria and the risk of developing end-stage renal disease. Kidney Int (2003) 3.73
Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med (2003) 3.05
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet (1983) 3.01
Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int (2006) 3.00
Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res Ed) (1982) 2.99
Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol (2003) 2.95
The burden of kidney disease: improving global outcomes. Kidney Int (2004) 2.94
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int (2003) 2.43
Relationship of uric acid with progression of kidney disease. Am J Kidney Dis (2007) 2.26
Hypertension-associated kidney disease: perhaps no more. J Am Soc Nephrol (2008) 1.68
Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol (2002) 1.34
Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med (1983) 1.25
Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol (2008) 1.25
Importance of blood pressure control in chronic kidney disease. J Am Soc Nephrol (2006) 1.21
Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis. Am Heart J (2008) 1.19
Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant (2009) 1.17
Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med (1995) 1.16
Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis (2001) 1.11
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens (2010) 1.07
Hypertension and kidney disease: a deadly connection. Curr Cardiol Rep (2006) 0.94
Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes. Scand J Clin Lab Invest (2009) 0.93
Current status of chronic kidney disease care in southeast Asia. Semin Nephrol (2009) 0.91
Uric acid and chronic kidney disease: new understanding of an old problem. Semin Nephrol (2011) 0.91
Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice. Br J Gen Pract (2010) 0.84
Hypertension and angiogenesis in the aging kidney: a review. Arch Gerontol Geriatr (2010) 0.84
Standards of medical care in diabetes. Diabetes Care (2006) 0.83
The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes. Am J Hypertens (2002) 0.81
Hypertension, hypertension control, and chronic kidney disease in a Malay population in Singapore. Asia Pac J Public Health (2010) 0.81
Diabetic renal disease: the quest for normotension--and beyond. Diabet Med (1995) 0.76
Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study. BMC Cardiovasc Disord (2014) 0.88
Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting. BMC Fam Pract (2014) 0.87
Methanol extract of Melastoma malabathricum leaves exerted antioxidant and liver protective activity in rats. BMC Complement Altern Med (2013) 0.86
Prevalence and predictors of resistant hypertension in a primary care setting: a cross-sectional study. BMC Fam Pract (2014) 0.79
The shaman told me so! Fam Med (2012) 0.75
Effects of calcium on the incidence of recurrent colorectal adenomas: A systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Medicine (Baltimore) (2017) 0.75
Visit-to-visit SBP variability and cardiovascular disease in a multiethnic primary care setting: 10-year retrospective cohort study. J Hypertens (2017) 0.75
OS 14-04 NUMBER OF BLOOD PRESSURE MEASUREMENTS NEEDED TO ESTIMATE LONG TERM VISIT-TO-VISIT SYSTOLIC BLOOD PRESSURE VARIABILITY FOR PREDICTING 10-YEAR CARDIOVASCULAR RISK. J Hypertens (2016) 0.75
OS 37-05 LONG-TERM VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE AND DECLINE IN RENAL FUNCTION IN HYPERTENSIVE PATIENTS OVER 15 YEARS. J Hypertens (2016) 0.75
OS 37-05 LONG-TERM VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE AND DECLINE IN RENAL FUNCTION IN HYPERTENSIVE PATIENTS OVER 15 YEARS. J Hypertens (2016) 0.75
OS 14-04 NUMBER OF BLOOD PRESSURE MEASUREMENTS NEEDED TO ESTIMATE LONG TERM VISIT-TO-VISIT SYSTOLIC BLOOD PRESSURE VARIABILITY FOR PREDICTING 10-YEAR CARDIOVASCULAR RISK. J Hypertens (2016) 0.75